Journal for ImmunoTherapy of Cancer (Nov 2023)
325 Armored STEAP2 CAR-T (AZD0754) alone and in combination with enzalutamide demonstrates anti-tumor activity across a range of STEAP2 expressing prostate cancer PDX models
Abstract
No abstracts available.